ENGENE HOLDINGS INC(ENGN)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ENGN ENGENE HOLDINGS INC

交易中 06-30 14:58:19 EDT

1.78

+0.00

-0.28%

最高1.87	最低1.76	成交量88.59万
今开1.79	昨收1.78	日振幅6.46%
总市值1.19亿	流通市值6,627万	总股本6,698万
成交额159.43万	换手率2.37%	流通股本3,733万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ENGN","market":"US","secType":"STK","nameCN":"ENGENE HOLDINGS INC","latestPrice":1.775,"timestamp":1782845899669,"preClose":1.78,"halted":0,"volume":885900,"delay":0,"changeRate":-0.002808988764045009,"floatShares":37332800,"shares":66984661,"eps":-2.122895,"marketStatus":"交易中","change":-0.005,"latestTime":"06-30 14:58:19 EDT","open":1.79,"high":1.87,"low":1.755,"amount":1594294.78611,"amplitude":0.064607,"askPrice":1.78,"askSize":2950,"bidPrice":1.77,"bidSize":1407,"shortable":3,"etf":0,"ttmEps":-2.122895,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1782849600000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":1.78,"preHourTrading":{"tag":"盘前","latestPrice":1.7798,"preClose":1.78,"latestTime":"09:23 EDT","volume":42,"amount":74.7462996,"timestamp":1782825807717,"change":-0.0002,"changeRate":-0.000112,"amplitude":0.005506},"postHourTrading":{"tag":"盘后","latestPrice":1.78,"preClose":1.78,"latestTime":"17:39 EDT","volume":127,"amount":224.61,"timestamp":1782769199413,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.880195,"impliedVol":0.3754,"impliedVolPercentile":0.3},"requestUrl":"/m/hq/s/ENGN","defaultTab":"news","newsList":[{"id":"1170325308","title":"ENGENE HOLDINGS INC 公布2026年第二季度财报并提供业务更新","url":"https://stock-news.laohu8.com/highlight/detail?id=1170325308","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1170325308?lang=zh_cn&edition=full","pubTime":"2026-06-15 21:31","pubTimestamp":1781530297,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC发布了其2026年第二季度的财务业绩，并同步更新了公司业务进展。\n公司宣布，已于2026年6月实施了一项裁员计划，规模约为员工总数的50%。此外，公司首席财务官Ryan Daws将于2026年7月15日离职。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148042920","title":"enGene Therapeutics预估重组成本570万至640万美元 非现金股票薪酬470万至500万美元 - SEC文件披露","url":"https://stock-news.laohu8.com/highlight/detail?id=1148042920","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148042920?lang=zh_cn&edition=full","pubTime":"2026-06-15 21:18","pubTimestamp":1781529499,"startTime":"0","endTime":"0","summary":"根据向美国证券交易委员会（SEC）提交的最新文件，enGene Therapeutics公司披露了其财务预估。该公司预计将产生一笔总额在570万美元至640万美元之间的重组相关成本。\n与此同时，文件还揭示，enGene Therapeutics计划确认一笔价值介于470万美元至500万美元的非现金股票薪酬费用。这笔费用预计将以股权激励的形式体现，不涉及公司现金流出。\n上述财务预估的披露，为市场提供了关于该公司近期成本结构变动与员工激励安排的更清晰视角。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108496190","title":"Piper Sandler下调enGene Holdings评级至中性 目标价砍至4美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1108496190","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108496190?lang=zh_cn&edition=full","pubTime":"2026-05-08 15:35","pubTimestamp":1778225707,"startTime":"0","endTime":"0","summary":"投资银行Piper Sandler宣布将enGene Holdings Inc的股票评级从\"增持\"下调至\"中性\"，同时将其目标股价从7美元大幅调降至4美元。此次评级调整反映出该机构对这家生物技术公司短期前景的谨慎态度。\n分析师在最新报告中指出，尽管enGene在基因治疗领域拥有独特技术平台，但近期临床进展和商业化时间表存在不确定性。目标价的大幅下调主要基于对研发里程碑达成周期的重新评估，以及当前生物科技板块的整体估值压力。\n市场数据显示，此次评级调整后，enGene股价可能面临新的下行压力。该股今年以来已累计下跌约35%，表现逊于同行业多数竞争对手。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1124898517","title":"ENGENE HOLDINGS INC：2.4%患者经历治疗中断，2.4%因不良事件终止治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1124898517","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1124898517?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:14","pubTimestamp":1778152455,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC最新临床数据显示，在接受治疗的患者中，有2.4%的比例经历了治疗中断。与此同时，另有2.4%的患者因出现不良事件而不得不终止治疗。\n这一数据反映了该疗法在安全性方面的表现。治疗中断通常指暂时停止用药，而治疗终止则意味着患者完全退出治疗方案。两者数据持平，均为2.4%，显示出一定的临床一致性。\n不良事件是评估药物安全性的关键指标。公司将继续监测这些事件的具体性质和严重程度，以进一步完善治疗方案。这些数据对于评估该疗法的风险收益比具有重要意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1167006419","title":"ENGENE HOLDINGS INC旗下疗法Detaimigene实现54%的任意时间完全缓解率，截至2026年4月21日六个月时达43%","url":"https://stock-news.laohu8.com/highlight/detail?id=1167006419","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1167006419?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:13","pubTimestamp":1778152395,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC公布的最新数据显示，其研发的基因疗法Detaimigene展现出卓越疗效。截至2026年4月21日，该疗法在治疗期间任意时间点达到的完全缓解率为54%，而在持续治疗六个月的时间节点，完全缓解率仍维持在43%的高水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195076086","title":"ENGENE HOLDINGS INC旗下Detalimogene疗法相关不良事件发生率达55%，多数症状轻微","url":"https://stock-news.laohu8.com/highlight/detail?id=1195076086","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1195076086?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:13","pubTimestamp":1778152391,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC公布的最新临床数据显示，其研究的Detalimogene疗法在试验过程中出现了治疗相关的不良事件，发生率为55%。不过，值得关注的是，这些报告中绝大多数的不良事件严重程度被评定为轻度，显示出该疗法在安全性方面具备一定的可控性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112241251","title":"ENGENE HOLDINGS INC 获得高达1亿美元资金，用于膀胱癌疗法Detalimogene的研发与商业化","url":"https://stock-news.laohu8.com/highlight/detail?id=1112241251","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112241251?lang=zh_cn&edition=full","pubTime":"2026-01-21 06:42","pubTimestamp":1768948933,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC 已成功获得一笔总额高达1亿美元的融资，这笔资金将专项用于其膀胱癌治疗药物Detalimogene的后续开发及商业化进程。此次融资为Detalimogene项目的推进提供了强有力的资金保障，有望加速该创新疗法的研发与市场应用。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601716098","title":"Engene Holdings Inc.盘中异动 临近午盘股价大跌5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601716098","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601716098?lang=zh_cn&edition=full","pubTime":"2026-01-07 00:38","pubTimestamp":1767717500,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日00时38分，Engene Holdings Inc.股票出现波动，股价大幅下挫5.04%。Engene Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.14%。Engene Holdings Inc.公司简介：enGene Holdings Inc是一家临床阶段的生物技术公司，致力于通过将治疗药物递送至黏膜组织和其他器官，推动基因医学的主流化应用，旨在为解决临床需求高的疾病创造新的途径。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107003821a4a4260a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107003821a4a4260a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139","DDX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108419306","title":"ENGENE HOLDINGS INC - 现金及可交易证券加上11月融资所得预计将为2028年下半年提供现金流支持","url":"https://stock-news.laohu8.com/highlight/detail?id=1108419306","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108419306?lang=zh_cn&edition=full","pubTime":"2025-12-23 05:16","pubTimestamp":1766438213,"startTime":"0","endTime":"0","summary":"ENGENE HOLDINGS INC - 现金及可交易证券加上11月融资所得预计将为2028年下半年提供现金流支持","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518789484","title":"enGene Holdings(ENGN.US)：2025年Q1财报实现营收0美元，前值为0美元；每股收益为-0.48美元，前值为-0.46美元，预期值为-0.38美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2518789484","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518789484?lang=zh_cn&edition=full","pubTime":"2025-03-11 05:45","pubTimestamp":1741643101,"startTime":"0","endTime":"0","summary":"enGene Holdings(ENGN.US)：2025年Q1财报实现营收0美元，前值为0美元；每股收益为-0.48美元，前值为-0.46美元，预期值为-0.38美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/03/11054548643207.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192034044","title":"enGene Holdings 2025年第一季度GAAP每股亏损$(0.48)，低于预期$(0.39)","url":"https://stock-news.laohu8.com/highlight/detail?id=1192034044","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1192034044?lang=zh_cn&edition=full","pubTime":"2025-03-11 04:14","pubTimestamp":1741637680,"startTime":"0","endTime":"0","summary":"enGene Holdings  公布季度每股亏损$，低于分析师共识预期$，下降23.08%。相比去年同期的每股亏损$，这是下降了4.35%。以上内容来自Benzinga Earnings专栏，原文如下：enGene Holdings  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 23.08 percent. This is a 4.35 percent decrease over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"enGene Holdings 2025年第一季度GAAP每股亏损$(0.48)，低于预期$(0.39)","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518222407","title":"Engene Holdings Inc.盘中异动 早盘股价大涨6.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518222407","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518222407?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:36","pubTimestamp":1741613793,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时36分，Engene Holdings Inc.股票出现波动，股价大幅上涨6.10%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.42%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Scisparc Ltd.涨幅较大，Scisparc Ltd.、Dogwood Therapeutics, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为447.98%、67.42%、50.45%，振幅较大的相关个股有Akero Therapeutics, Inc.、Seer, Inc.、珐博进，振幅分别为100.05%、98.72%、98.49%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021363398a29e02&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021363398a29e02&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517294715","title":"Engene Holdings Inc.盘中异动 股价大跌5.60%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517294715","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517294715?lang=zh_cn&edition=full","pubTime":"2025-03-06 01:30","pubTimestamp":1741195858,"startTime":"0","endTime":"0","summary":"北京时间2025年03月06日01时30分，Engene Holdings Inc.股票出现异动，股价大幅下跌5.60%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为1.24%。其相关个股中，Chimerix, Inc.、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 、Celularity Inc.涨幅较大，Silexion Therapeutics Corp、Tc Biopharm  Plc、Bioxcel Therapeutics, Inc.较为活跃，换手率分别为935.88%、304.12%、292.38%，振幅较大的相关个股有Nkgen Biotech, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Celularity Inc.，振幅分别为82.59%、54.27%、47.22%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306013058989d6e13&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250306013058989d6e13&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514386190","title":"Engene Holdings Inc.盘中异动 大幅上涨7.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514386190","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514386190?lang=zh_cn&edition=full","pubTime":"2025-02-27 22:44","pubTimestamp":1740667477,"startTime":"0","endTime":"0","summary":"北京时间2025年02月27日22时44分，Engene Holdings Inc.股票出现波动，股价急速上涨7.58%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.75%。其相关个股中，Cero Therapeutics Holdings Inc C/Wts 13/02/2029 、Tiziana Life Sciences Ltd、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Moleculin Biotech, Inc.、Aeon Biopharma, Inc.较为活跃，换手率分别为456.35%、95.15%、83.14%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Tiziana Life Sciences Ltd，振幅分别为59.85%、21.99%、17.35%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272244379632b3b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502272244379632b3b4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514856616","title":"Engene Holdings Inc.盘中异动 股价大涨5.34%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514856616","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514856616?lang=zh_cn&edition=full","pubTime":"2025-02-26 22:34","pubTimestamp":1740580471,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日22时34分，Engene Holdings Inc.股票出现异动，股价快速拉升5.34%。截至发稿，该股报5.92美元/股，成交量1341股，换手率0.00%，振幅2.67%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.21%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223431abddedbe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250226223431abddedbe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ENGN","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514775486","title":"Engene Holdings Inc.盘中异动 早盘快速下跌5.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514775486","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514775486?lang=zh_cn&edition=full","pubTime":"2025-02-25 00:08","pubTimestamp":1740413296,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日00时08分，Engene Holdings Inc.股票出现波动，股价急速跳水5.09%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.07%。其相关个股中，Pepgen Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Estrella Immunopharma Inc C/Wts 29/09/2028涨幅较大，Pepgen Inc.、Aditxt, Inc.、Allarity Therapeutics, Inc.较为活跃，换手率分别为240.54%、104.55%、32.30%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、60 Degrees Pharmaceuticals Inc C/Wts 12/07/2028 ，振幅分别为162.04%、55.69%、53.34%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000817962eaf0a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225000817962eaf0a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513965832","title":"Engene Holdings Inc.盘中异动 股价大涨9.31%报6.69美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513965832","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513965832?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148312,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Engene Holdings Inc.股票出现异动，股价大幅拉升9.31%。截至发稿，该股报6.69美元/股，成交量1737股，换手率0.00%，振幅3.59%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223152962b7b53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223152962b7b53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512655141","title":"Engene Holdings Inc.盘中异动 早盘股价大涨7.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512655141","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512655141?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:34","pubTimestamp":1739889243,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时34分，Engene Holdings Inc.股票出现波动，股价急速上涨7.12%。截至发稿，该股报6.32美元/股，成交量4583股，换手率0.01%，振幅5.08%。Engene Holdings Inc.股票所在的生物技术行业中，整体跌幅为0.04%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223403a24aad6d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223403a24aad6d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511961531","title":"瑞银：下调enGene Holdings(ENGN.US)评级，由买入调整至中性评级, 目标价由34.00美元调整至7.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511961531","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511961531?lang=zh_cn&edition=full","pubTime":"2025-02-15 02:12","pubTimestamp":1739556758,"startTime":"0","endTime":"0","summary":"瑞银：下调enGene Holdings(ENGN.US)评级，由买入调整至中性评级, 目标价由34.00美元调整至7.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/15021248179491.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["ENGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511691857","title":"Engene Holdings Inc.盘中异动 股价大涨5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511691857","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511691857?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543491,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Engene Holdings Inc.股票出现波动，股价快速拉升5.44%。截至发稿，该股报6.59美元/股，成交量5275股，换手率0.01%，振幅4.64%。Engene Holdings Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Engene Holdings Inc.公司简介：enGene Holdings Inc .是一家临床阶段的生物技术公司，致力于开发基因疗法以改善患者的生活。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223131a24600c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223131a24600c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","VRPX","BK4007","ENGN"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.engene.com","stockEarnings":[{"period":"1week","weight":0.0533},{"period":"1month","weight":-0.0378},{"period":"3month","weight":-0.7386},{"period":"6month","weight":-0.8029},{"period":"1year","weight":-0.5137},{"period":"ytd","weight":-0.8029}],"compareEarnings":[{"period":"1week","weight":-0.0046},{"period":"1month","weight":-0.0205},{"period":"3month","weight":0.1394},{"period":"6month","weight":0.0866},{"period":"1year","weight":0.2051},{"period":"ytd","weight":0.0866}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"enGene Therapeutics Inc.于2023年4月24日根据加拿大联邦法律注册为14963148 Canada Inc.。该公司是一家临床阶段的生物技术公司，通过向黏膜组织和其他器官提供治疗药物，将基因医学纳入主流，目标是创造新的方法来解决临床需求高的疾病，从非肌肉浸润性膀胱癌（NMIBC）开始。该公司正在开发基于其新型和专有的双重衍生的壳聚糖或“DDX”基因递送平台的非病毒基因疗法，该平台允许将多种基因货物直接本地化递送至黏膜组织和其他器官。","exchange":"NASDAQ","name":"ENGENE HOLDINGS INC","nameEN":"ENGENE HOLDINGS INC"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ENGENE HOLDINGS INC(ENGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供ENGENE HOLDINGS INC(ENGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"ENGENE HOLDINGS INC,ENGN,ENGENE HOLDINGS INC股票,ENGENE HOLDINGS INC股票老虎,ENGENE HOLDINGS INC股票老虎国际,ENGENE HOLDINGS INC行情,ENGENE HOLDINGS INC股票行情,ENGENE HOLDINGS INC股价,ENGENE HOLDINGS INC股市,ENGENE HOLDINGS INC股票价格,ENGENE HOLDINGS INC股票交易,ENGENE HOLDINGS INC股票购买,ENGENE HOLDINGS INC股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ENGENE HOLDINGS INC(ENGN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供ENGENE HOLDINGS INC(ENGN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}